Biocept Inc (NASDAQ:BIOC)

4.55
BATS BZX Real-Time Price
As of 11:24am ET
 +0.035 / +0.78%
Today’s Change
2.11
Today|||52-Week Range
13.00
+59.09%
Year-to-Date
SECTOR
Health Services
INDUSTRY
Medical/Nursing Services
MARKET CAP
$61.5M

Company Description

Biocept, Inc. is an oncology laboratory service company, which focuses on the development and marketing of novel laboratory products in the detection of rare cells to include circulating tumor cells. It develops and commercializes proprietary circulating tumor cell and circulating tumor DNA tests utilizing a standard blood sample. The company utilizes cell enrichment and extraction technology for the detection and analysis of circulating tumor DNA tests. It also offers services to other laboratory testing providers, academic institutions, research organizations, biopharmaceutical companies and clinical trial support and specific oncogenic alterations. Biocept was founded on May 12, 1997 and is headquartered in San Diego, CA.

Contact Information

Biocept, Inc.
5810 Nancy Ridge Drive
San Diego California 92121-2840
P:(858) 320-8200
Investor Relations:

Employees

Shareholders

Mutual fund holders6.16%
Other institutional2.02%
Individual stakeholders--

Top Executives

Michael W. NallPresident, Chief Executive Officer & Director
Timothy C. KennedyCFO, Senior VP-Operations & Secretary
Pavel TsinbergDirector-Technology Development
Lyle J. ArnoldChief Scientific Officer & Senior Vice President
Veena M. SinghSenior Medical Director